Consistent with animal model, patients with impaired glucose tolerance and type 2 diabetes also had a lower plasma concentration of IL10 [24].Therefore, it is speculated that the administration of exogenous or endogenous IL10 could be an effective strategy for treating obesity and metabolic syndromes induced by HFD. Here, IL10 is linked to type 2 diabetes mellitus.